{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:51:47Z","timestamp":1766159507377,"version":"3.28.0"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"41","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Compound 861 (Cpd861) is a traditional Chinese herbal compound for the treatment\nof hepatic fibrosis (HF). In the current investigation, Cpd861 has been demonstrated to have an underlying\nmolecular mechanism and material foundation for the treatment of HF through network pharmacology, Mendelian\nrandomization (MR), and molecular docking.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Public databases were consulted for Cpd861 constituents and HF targets. Protein-protein interactions\n(PPIs) were established using STRING software, followed by Gene Ontology (GO) and Kyoto Encyclopedia\nof Genes and Genomes (KEGG) pathway enrichment analyses. To elucidate the causal relationship between\npotential targets and liver injury, MR was used as a methodological tool. Finally, a molecular docking\nanalysis was conducted between the active compound and the key target.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We obtained 174 active ingredients and 113 intersecting genes. Through the PPI network, high-degree\ntargets were identified, namely CTNNB1, ESR1, FOS, MDM2, CCND1, TP53, RELA, and BCL2. As\nshown by GO and KEGG pathway enrichment analyses, Cpd861 functions through xenobiotic stimulus and\noxidative stress-related genes, as well as the PI3K-AKT and non-alcoholic fatty liver disease (NAFLD) signaling\npathways. The results of MR showed that MDM2 and BCL2 had a causal relationship with liver injury.\nMolecular docking results showed that several active compounds in Cpd861 were stably bound to BCL2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We obtained 174 active ingredients and 113 intersecting genes. Through the PPI network, high-degree\ntargets were identified, namely CTNNB1, ESR1, FOS, MDM2, CCND1, TP53, RELA, and BCL2. As\nshown by GO and KEGG pathway enrichment analyses, Cpd861 functions through xenobiotic stimulus and\noxidative stress-related genes, as well as the PI3K-AKT and non-alcoholic fatty liver disease (NAFLD) signaling\npathways. The results of MR showed that MDM2 and BCL2 had a causal relationship with liver injury.\nMolecular docking results showed that several active compounds in Cpd861 were stably bound to BCL2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study made predictions regarding the efficacious components, as well as potential targets\nand pathways of Cpd861 in the therapy of HF. This will open up a new perspective for further investigation of\nthe molecular mechanism of Cpd861 in the treatment of HF.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113816128328422240820105654","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:13:35Z","timestamp":1726460015000},"page":"3291-3310","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms"],"prefix":"10.2174","volume":"30","author":[{"given":"Yaning","family":"Lyu","sequence":"first","affiliation":[{"name":"School of Nursing, Shandong Second Medical University, Weifang, 261021, Shandong, China"},{"name":"School of Nursing, Jining Medical\nUniversity, Jining, 272067, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xifeng","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Nursing, Shandong Second Medical University, Weifang, 261021, Shandong, China"},{"name":"School of Nursing, Jining Medical\nUniversity, Jining, 272067, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Nursing, Shandong First Medical University (Shandong Academy of Medical\nSciences), Taian, 271000, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"School of Nursing, Shandong Second Medical University, Weifang, 261021, Shandong, China"},{"name":"School of Nursing, Jining Medical\nUniversity, Jining, 272067, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[{"name":"School of Nursing, Jining Medical\nUniversity, Jining, 272067, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Nursing, Jining Medical\nUniversity, Jining, 272067, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Beijing Obstetrics and Gynecology Hospital,\nBeijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, 100026, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chi","sequence":"additional","affiliation":[{"name":"School of Nursing, Jining Medical\nUniversity, Jining, 272067, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"304","volume":"8","author":"Guo Y.C.","year":"2020","unstructured":"Guo Y.C.; Lu L.G.; Antihepatic fibrosis drugs in clinical trials. J Clin Transl Hepatol  2020,8(3),304-312","journal-title":"J Clin Transl Hepatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"Aydin M.M.","year":"2018","unstructured":"Aydin M.M.; Ak\u00e7al\u0131 K.C.; Liver fibrosis. Turk J Gastroenterol  2018,29(1),14-21","journal-title":"Turk J Gastroenterol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"Friedman S.L.","year":"2022","unstructured":"Friedman S.L.; Pinzani M.; Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology  2022,75(2),473-488","journal-title":"Hepatology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/liv.14940","volume":"41","author":"Cheng D.","year":"2021","unstructured":"Cheng D.; Chai J.; Wang H.; Fu L.; Peng S.; Ni X.; Hepatic macrophages: Key players in the development and progression of liver fibrosis. Liver Int  2021,41(10),2279-2294","journal-title":"Liver Int"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"Lee Y.A.","year":"2015","unstructured":"Lee Y.A.; Wallace M.C.; Friedman S.L.; Pathobiology of liver fibrosis: A translational success story. Gut  2015,64(5),830-841","journal-title":"Gut"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-018-1272-8","volume":"10","author":"George J.","year":"2019","unstructured":"George J.; Tsuchishima M.; Tsutsumi M.; Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis  2019,10(1),18","journal-title":"Cell Death Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.apsb.2018.11.004","volume":"9","author":"Zhou J.","year":"2019","unstructured":"Zhou J.; Huang N.; Guo Y.; Cui S.; Ge C.; He Q.; Pan X.; Wang G.; Wang H.; Hao H.; Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis. Acta Pharm Sin B  2019,9(3),526-536","journal-title":"Acta Pharm Sin B"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"Friedman S.L.","year":"2010","unstructured":"Friedman S.L.; Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol  2010,7(8),425-436","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"D976","DOI":"10.1093\/nar\/gky987","volume":"47","author":"Xu H.Y.","year":"2019","unstructured":"Xu H.Y.; Zhang Y.Q.; Liu Z.M.; Chen T.; Lv C.Y.; Tang S.H.; Zhang X.B.; Zhang W.; Li Z.Y.; Zhou R.R.; Yang H.J.; Wang X.J.; Huang L.Q.; ETCM: An encyclopaedia of traditional Chinese medicine. Nucleic Acids Res  2019,47(D1),D976-D982","journal-title":"Nucleic Acids Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.3892\/mmr.2016.5071","volume":"13","author":"Hou F.","year":"2016","unstructured":"Hou F.; Liu R.; Liu X.; Cui L.; Wen Y.; Yan S.; Yin C.; Attenuation of liver fibrosis by herbal compound 861 via upregulation of BMP-7\/Smad signaling in the bile duct ligation model rat. Mol Med Rep  2016,13(5),4335-4342","journal-title":"Mol Med Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1542-3565(04)00455-0","volume":"2","author":"Levy C.","year":"2004","unstructured":"Levy C.; Seeff L.; Lindor K.; Use of herbal supplements for chronic liver disease. Clin Gastroenterol Hepatol  2004,2(11),947-956","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12906-019-2787-y","volume":"6","author":"Zhou W.","year":"2020","unstructured":"Zhou W.; Wu J.R.; Zhu Y.L.; Meng Z.Q.; Liu X.K.; Liu S.Y.; Ni M.W.; Jia S.S.; Zhang J.Y.; Guo S.Y.; Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology. BMC Complement Med Ther  2020,6,6","journal-title":"BMC Complement Med Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"Ru J.","year":"2014","unstructured":"Ru J.; Li P.; Wang J.; Zhou W.; Li B.; Huang C.; Li P.; Guo Z.; Tao W.; Yang Y.; Xu X.; Li Y.; Wang Y.; Yang L.; TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminform  2014,6(1),13","journal-title":"J Cheminform"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/ijms13066964","volume":"13","author":"Xu X.","year":"2012","unstructured":"Xu X.; Zhang W.; Huang C.; Li Y.; Yu H.; Wang Y.; Duan J.; Ling Y.; A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci  2012,13(6),6964-6982","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","volume":"145","author":"Tao W.","year":"2013","unstructured":"Tao W.; Xu X.; Wang X.; Li B.; Wang Y.; Li Y.; Yang L.; Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol  2013,145(1),1-10","journal-title":"J Ethnopharmacol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","volume":"54","author":"Stelzer G","year":"2016","unstructured":"Stelzer G; Rosen N; Plaschkes I; Zimmerman S; Twik M; Fishilevich S; Stein TI; Nudel R; Lieder I; Mazor Y; Kaplan S; Dahary D; Warshawsky D; Guan-Golan Y; Kohn A; Rappaport N; Safran M; Lancet D; The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics  2016,54,1.30.1-1.30.33","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"Amberger J.S.","year":"2015","unstructured":"Amberger J.S.; Bocchini C.A.; Schiettecatte F.; Scott A.F.; Hamosh A.; OMIM.org: Online Mendelian Inheritance in Man (OMIM), an online catalog of human genes and genetic disorders. Nucleic Acids Res  2015,43(D1),D789-D798","journal-title":"Nucleic Acids Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e1417","DOI":"10.1002\/wsbm.1417","volume":"10","author":"Barbarino J.M.","year":"2018","unstructured":"Barbarino J.M.; Whirl-Carrillo M.; Altman R.B.; Klein T.E.; PharmGKB: A worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med  2018,10(4),e1417","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Zhou Y.","year":"2023","unstructured":"Zhou Y.; Zhang Y.; Zhao D.; Yu X.; Shen X.; Zhou Y.; Wang S.; Qiu Y.; Chen Y.; Zhu F.; TTD: Therapeutic target database describing target druggability information. Nucleic Acids Res  2023,52(D1),D1465-D1477","journal-title":"Nucleic Acids Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"Wishart D.S.","year":"2018","unstructured":"Wishart D.S.; Feunang Y.D.; Guo A.C.; Lo E.J.; Marcu A.; Grant J.R.; Sajed T.; Johnson D.; Li C.; Sayeeda Z.; Assempour N.; Iynkkaran I.; Liu Y.; Maciejewski A.; Gale N.; Wilson A.; Chin L.; Cummings R.; Le D.; Pon A.; Knox C.; Wilson M.; DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res  2018,46(D1),D1074-D1082","journal-title":"Nucleic Acids Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"Shannon P.","year":"2003","unstructured":"Shannon P.; Markiel A.; Ozier O.; Baliga N.S.; Wang J.T.; Ramage D.; Amin N.; Schwikowski B.; Ideker T.; Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res  2003,13(11),2498-2504","journal-title":"Genome Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"Szklarczyk D.","year":"2021","unstructured":"Szklarczyk D.; Gable A.L.; Nastou K.C.; Lyon D.; Kirsch R.; Pyysalo S.; Doncheva N.T.; Legeay M.; Fang T.; Bork P.; Jensen L.J.; von Mering C.; The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res  2021,49(D1),D605-D612","journal-title":"Nucleic Acids Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"106293","DOI":"10.1016\/j.compbiomed.2022.106293","volume":"151","author":"Zhang W.","year":"2022","unstructured":"Zhang W.; Tian W.; Wang Y.; Jin X.; Guo H.; Wang Y.; Tang Y.; Yao X.; Explore the mechanism and substance basis of Mahuang FuziXixin decoction for the treatment of lung cancer based on network pharmacology and molecular docking. Comput Biol Med  2022,151(Pt A),106293","journal-title":"Comput Biol Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymeth.2014.02.016","volume":"67","author":"Li M.","year":"2014","unstructured":"Li M.; Zheng R.; Zhang H.; Wang J.; Pan Y.; Effective identification of essential proteins based on priori knowledge, network topology and gene expressions. Methods  2014,67(3),325-333","journal-title":"Methods"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"17362","DOI":"10.1038\/s41598-018-35791-9","volume":"8","author":"Song W.","year":"2018","unstructured":"Song W.; Ni S.; Fu Y.; Wang Y.; Uncovering the mechanism of Maxing Ganshi decoction on asthma from a systematic perspective: A network pharmacology study. Sci Rep  2018,8(1),17362","journal-title":"Sci Rep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.2147\/CCID.S425295","volume":"16","author":"Ji C.","year":"2023","unstructured":"Ji C.; Ma J.; Feng C.; Zhu H.; Gao Y.; Huang J.; Shen H.; Wei Y.; Promotion of hair regrowth in androgenetic alopecia with supplemented Erzhi Wan: Exploring its mechanism using network pharmacology and molecular docking. Clin Cosmet Investig Dermatol  2023,16,2995-3022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.compbiomed.2022.105454","volume":"145","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Yuan Y.; Wang W.; He Y.; Zhong H.; Zhou X.; Chen Y.; Cai X.J.; Liu L.; Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking. Comput Biol Med  2022,145,105454","journal-title":"Comput Biol Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.; KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res  2000,28(1),27-30","journal-title":"Nucleic Acids Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"Wu T.","year":"2021","unstructured":"Wu T.; Hu E.; Xu S.; Chen M.; Guo P.; Dai Z.; Feng T.; Zhou L.; Tang W.; Zhan L.; Fu X.; Liu S.; Bo X.; Yu G.; clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation  2021,2(3),100141","journal-title":"Innovation"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gepi.22522","volume":"47","author":"Mounier N.","year":"2023","unstructured":"Mounier N.; Kutalik Z.; Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol  2023,47(4),314-331","journal-title":"Genet Epidemiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"Burgess S.","year":"2017","unstructured":"Burgess S.; Thompson S.G.; Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol  2017,32(5),377-389","journal-title":"Eur J Epidemiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1063110","DOI":"10.3389\/fimmu.2022.1063110","volume":"13","author":"Jin T.","year":"2022","unstructured":"Jin T.; Huang W.; Cao F.; Yu X.; Guo S.; Ying Z.; Xu C.; Causal association between systemic lupus erythematosus and the risk of dementia: A Mendelian randomization study. Front Immunol  2022,13,1063110","journal-title":"Front Immunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2018.4175","volume":"76","author":"Choi K.W.","year":"2019","unstructured":"Choi K.W.; Chen C.Y.; Stein M.B.; Klimentidis Y.C.; Wang M.J.; Koenen K.C.; Smoller J.W.; Assessment of bidirectional relationships between physical activity and depression among adults. JAMA Psychiatry  2019,76(4),399-408","journal-title":"JAMA Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"Verbanck M.","year":"2018","unstructured":"Verbanck M.; Chen C.Y.; Neale B.; Do R.; Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet  2018,50(5),693-698","journal-title":"Nat Genet"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"114794","DOI":"10.1016\/j.psychres.2022.114794","volume":"316","author":"Wu Y.","year":"2022","unstructured":"Wu Y.; Li Y.; Zhu J.; Long J.; Shared genetics and causality underlying epilepsy and attention-deficit hyperactivity disorder. Psychiatry Res  2022,316,114794","journal-title":"Psychiatry Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The protein data bank. Nucleic Acids Res  2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"Kim S.","year":"2016","unstructured":"Kim S.; Thiessen P.A.; Bolton E.E.; Chen J.; Fu G.; Gindulyte A.; Han L.; He J.; He S.; Shoemaker B.A.; Wang J.; Yu B.; Zhang J.; Bryant S.H.; PubChem substance and compound databases. Nucleic Acids Res  2016,44(D1),D1202-D1213","journal-title":"Nucleic Acids Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"115210","DOI":"10.1016\/j.biopha.2023.115210","volume":"165","author":"Ji L.","year":"2023","unstructured":"Ji L.; Song T.; Ge C.; Wu Q.; Ma L.; Chen X.; Chen T.; Chen Q.; Chen Z.; Chen W.; Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation. Biomed Pharmacother  2023,165,115210","journal-title":"Biomed Pharmacother"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"btad675","DOI":"10.1093\/bioinformatics\/btad675","volume":"39","author":"Rosignoli S.","year":"2023","unstructured":"Rosignoli S.; di Paola L.; Paiardini A.; PyPCN: Protein contact networks in PyMOL. Bioinformatics  2023,39(11),btad675","journal-title":"Bioinformatics"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","volume":"21","author":"Zhang Z.","year":"2023","unstructured":"Zhang Z.; Shang J.; Yang Q.; Dai Z.; Liang Y.; Lai C.; Feng T.; Zhong D.; Zou H.; Sun L.; Su Y.; Yan S.; Chen J.; Yao Y.; Shi Y.; Huang X.; Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism. J Nanobiotechnol  2023,21(1),29","journal-title":"J Nanobiotechnol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","volume":"45","author":"Lotersztajn S.","year":"2005","unstructured":"Lotersztajn S.; Julien B.; Teixeira-Clerc F.; Grenard P.; Mallat A.; Hepatic fibrosis: Molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol  2005,45(1),605-628","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12906-018-2119-7","volume":"18","author":"Chi C.","year":"2018","unstructured":"Chi C.; Liu X.; Hou F.; Yu X.; Li C.; Cui L.; Liu R.; Yin C.; Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-\u03b21\/Smad\/SnoN pathway in bile duct-ligated rats. BMC Complement Altern Med  2018,18(1),52","journal-title":"BMC Complement Altern Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1080\/15548627.2022.2048432","volume":"18","author":"Yang C.","year":"2022","unstructured":"Yang C.; Tao H.; Zhang H.; Xia Y.; Bai J.; Ge G.; Li W.; Zhang W.; Xiao L.; Xu Y.; Wang Z.; Gu Y.; Yang H.; Liu Y.; Geng D.; TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. Autophagy  2022,18(12),2817-2829","journal-title":"Autophagy"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"Kaloni D.","year":"2023","unstructured":"Kaloni D.; Diepstraten S.T.; Strasser A.; Kelly G.L.; BCL-2 protein family: Attractive targets for cancer therapy. Apoptosis  2023,28(1-2),20-38","journal-title":"Apoptosis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","volume":"65","author":"Mota M.","year":"2016","unstructured":"Mota M.; Banini B.A.; Cazanave S.C.; Sanyal A.J.; Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism  2016,65(8),1049-1061","journal-title":"Metabolism"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.3390\/molecules27227883","volume":"27","author":"Yang W.","year":"2022","unstructured":"Yang W.; Shao F.; Wang J.; Shen T.; Zhao Y.; Fu X.; Zhang L.; Li H.; Ethyl acetate extract from Artemisia argyi prevents liver damage in ConA-induced immunological liver injury mice via Bax\/Bcl-2 and TLR4\/MyD88\/NF-\u03baB signaling pathways. Molecules  2022,27(22),7883","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.fct.2007.05.015","volume":"45","author":"Harwood M.","year":"2007","unstructured":"Harwood M.; Danielewska-Nikiel B.; Borzelleca J.F.; Flamm G.W.; Williams G.M.; Lines T.C.; A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic\/carcinogenic properties. Food Chem Toxicol  2007,45(11),2179-2205","journal-title":"Food Chem Toxicol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1002\/ptr.7144","volume":"35","author":"Hosseini A.","year":"2021","unstructured":"Hosseini A.; Razavi B.M.; Banach M.; Hosseinzadeh H.; Quercetin and metabolic syndrome: A review. Phytother Res  2021,35(10),5352-5364","journal-title":"Phytother Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2174\/092986709787909578","volume":"16","author":"Jagtap S.","year":"2009","unstructured":"Jagtap S.; Meganathan K.; Wagh V.; Winkler J.; Hescheler J.; Sachinidis A.; Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem  2009,16(12),1451-1462","journal-title":"Curr Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jcb.30162","volume":"123","author":"Alam S.","year":"2022","unstructured":"Alam S.; Mohammad T.; Padder R.A.; Hassan M.I.; Husain M.; Thymoquinone and quercetin induce enhanced apoptosis in non-small cell lung cancer in combination through the Bax\/Bcl2 cascade. J Cell Biochem  2022,123(2),259-274","journal-title":"J Cell Biochem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.3390\/ijms22168939","volume":"22","author":"Cano-Mart\u00ednez A.","year":"2021","unstructured":"Cano-Mart\u00ednez A.; Bautista-P\u00e9rez R.; Castrej\u00f3n-T\u00e9llez V.; Carre\u00f3n-Torres E.; P\u00e9rez-Torres I.; D\u00edaz-D\u00edaz E.; Flores-Estrada J.; Guarner-Lans V.; Rubio-Ru\u00edz M.E.; Resveratrol and quercetin as regulators of inflammatory and purinergic receptors to attenuate liver damage associated to metabolic syndrome. Int J Mol Sci  2021,22(16),8939","journal-title":"Int J Mol Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"9289","DOI":"10.1038\/s41598-017-09673-5","volume":"7","author":"Wu L.","year":"2017","unstructured":"Wu L.; Zhang Q.; Mo W.; Feng J.; Li S.; Li J.; Liu T.; Xu S.; Wang W.; Lu X.; Yu Q.; Chen K.; Xia Y.; Lu J.; Xu L.; Zhou Y.; Fan X.; Guo C.; Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-\u03b21\/Smads and PI3K\/Akt pathways. Sci Rep  2017,7(1),9289","journal-title":"Sci Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainres.2016.02.013","volume":"1636","author":"Zhang L.","year":"2016","unstructured":"Zhang L.; Zhang X.; Zhang C.; Bai X.; Zhang J.; Zhao X.; Chen L.; Wang L.; Zhu C.; Cui L.; Chen R.; Zhao T.; Zhao Y.; Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo. Brain Res  2016,1636,130-141","journal-title":"Brain Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.etp.2015.04.008","volume":"67","author":"Malik S.","year":"2015","unstructured":"Malik S.; Bhatia J.; Suchal K.; Gamad N.; Dinda A.K.; Gupta Y.K.; Arya D.S.; Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Exp Toxicol Pathol  2015,67(7-8),427-433","journal-title":"Exp Toxicol Pathol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"115022","DOI":"10.1016\/j.jep.2022.115022","volume":"289","author":"Zhang L.","year":"2022","unstructured":"Zhang L.; Tian Y.; Zhao P.; Feng S.; Han X.; Li J.; Network pharmacology analysis uncovers the effect on apoptotic pathway by Bu-Fei formula for COPD treatment. J Ethnopharmacol  2022,289,115022","journal-title":"J Ethnopharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopha.2017.02.087","volume":"89","author":"Wu Y.","year":"2017","unstructured":"Wu Y.; Zhang W.; Li M.; Cao D.; Yang X.; Gong J.; Nobiletin ameliorates ischemia\u2013reperfusion injury by suppressing the function of Kupffer cells after liver transplantation in rats. Biomed Pharmacother  2017,89,732-741","journal-title":"Biomed Pharmacother"},{"key":"ref=57","first-page":"5722","volume":"45","author":"Feng Y.Y.","year":"2020","unstructured":"Feng Y.Y.; Yan J.Y.; Xia X.; Liang J.Q.; Li F.; Xie T.F.; Luo W.S.; Feng J.F.; Effect and mechanism of total flavonoids of Lichi Semen on CCl-induced liver fibrosis in rats, and prediction of Q-marker. Zhongguo Zhongyao Zazhi  2020,45(23),5722-5731","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2015.03.035","volume":"127","author":"Devi K.S.P.","year":"2015","unstructured":"Devi K.S.P.; Mishra D.; Roy B.; Ghosh S.K.; Maiti T.K.; Assessing the immunomodulatory role of heteroglycan in a tumor spheroid and macrophage co-culture model system. Carbohydr Polym  2015,127,1-10","journal-title":"Carbohydr Polym"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/ijms22041619","volume":"22","author":"Simunkova M.","year":"2021","unstructured":"Simunkova M.; Barbierikova Z.; Jomova K.; Hudecova L.; Lauro P.; Alwasel S.H.; Alhazza I.; Rhodes C.J.; Valko M.; Antioxidant vs. prooxidant properties of the flavonoid, kaempferol, in the presence of Cu(II) ions: A ROS-scavenging activity, fenton reaction and DNA damage study. Int J Mol Sci  2021,22(4),1619","journal-title":"Int J Mol Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/molecules24122277","volume":"24","author":"Imran M.","year":"2019","unstructured":"Imran M.; Salehi B.; Sharifi-Rad J.; Aslam Gondal T.; Saeed F.; Imran A.; Shahbaz M.; Tsouh Fokou P.V.; Umair Arshad M.; Khan H.; Guerreiro S.G.; Martins N.; Estevinho L.M.; Kaempferol: A key emphasis to its anticancer potential. Molecules  2019,24(12),2277","journal-title":"Molecules"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.3390\/ijms22168847","volume":"22","author":"Tie F.","year":"2021","unstructured":"Tie F.; Ding J.; Hu N.; Dong Q.; Chen Z.; Wang H.; Kaempferol and kaempferide attenuate oleic acid-induced lipid accumulation and oxidative stress in HepG2 cells. Int J Mol Sci  2021,22(16),8847","journal-title":"Int J Mol Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"115113","DOI":"10.1016\/j.biopha.2023.115113","volume":"165","author":"Li N.","year":"2023","unstructured":"Li N.; Yin L.; Shang J.; Liang M.; Liu Z.; Yang H.; Qiang G.; Du G.; Yang X.; Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway. Biomed Pharmacother  2023,165,115113","journal-title":"Biomed Pharmacother"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1002\/jcb.26391","volume":"119","author":"Moradzadeh M.","year":"2018","unstructured":"Moradzadeh M.; Tabarraei A.; Sadeghnia H.R.; Ghorbani A.; Mohamadkhani A.; Erfanian S.; Sahebkar A.; Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes. J Cell Biochem  2018,119(2),2288-2297","journal-title":"J Cell Biochem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/13880209.2021.1877734","volume":"59","author":"BinMowyna M.N.","year":"2021","unstructured":"BinMowyna M.N.; AlFaris N.A.; Kaempferol suppresses acetaminophen-induced liver damage by upregulation\/activation of SIRT1. Pharm Biol  2021,59(1),144-154","journal-title":"Pharm Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"106005","DOI":"10.1016\/j.phrs.2021.106005","volume":"175","author":"Xiao X.","year":"2022","unstructured":"Xiao X.; Hu Q.; Deng X.; Shi K.; Zhang W.; Jiang Y.; Ma X.; Zeng J.; Wang X.; Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. Pharmacol Res  2022,175,106005","journal-title":"Pharmacol Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"155125","DOI":"10.1016\/j.phymed.2023.155125","volume":"121","author":"Cao R.","year":"2023","unstructured":"Cao R.; Cao C.; Hu X.; Du K.; Zhang J.; Li M.; Li B.; Lin H.; Zhang A.; Li Y.; Wu L.; Huang Y.; Kaempferol attenuates carbon tetrachloride (CCl)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS. Phytomedicine  2023,121,155125","journal-title":"Phytomedicine"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"154881","DOI":"10.1016\/j.phymed.2023.154881","volume":"116","author":"Wen R.","year":"2023","unstructured":"Wen R.; Dong X.; Zhuang H.; Pang F.; Ding S.; Li N.; Mai Y.; Zhou S.; Wang J.; Zhang J.; Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2\/xCT\/GPX4 regulatory axis. Phytomedicine  2023,116,154881","journal-title":"Phytomedicine"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"105387","DOI":"10.1016\/j.phrs.2020.105387","volume":"164","author":"Singh S.","year":"2021","unstructured":"Singh S.; Meena A.; Luqman S.; Baicalin mediated regulation of key signaling pathways in cancer. Pharmacol Res  2021,164,105387","journal-title":"Pharmacol Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.7150\/ijms.46108","volume":"17","author":"AlSaad A.M.S.","year":"2020","unstructured":"AlSaad A.M.S.; Mohany M.; Almalki M.S.; Almutham I.; Alahmari A.A.; AlSulaiman M.; Al-Rejaie S.S.; Baicalein neutralizes hypercholesterolemia-induced aggravation of oxidative injury in rats. Int J Med Sci  2020,17(9),1156-1166","journal-title":"Int J Med Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cellsig.2018.06.013","volume":"50","author":"Zhang C.","year":"2018","unstructured":"Zhang C.; Chang C.; Gao H.; Wang Q.; Zhang F.; Xu C.; MiR-429 regulates rat liver regeneration and hepatocyte proliferation by targeting JUN\/MYC\/BCL2\/CCND1 signaling pathway. Cell Signal  2018,50,80-89","journal-title":"Cell Signal"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ptr.7613","volume":"37","author":"Qi J.","year":"2023","unstructured":"Qi J.; Li J.; Bie B.; Shi M.; Zhu M.; Tian J.; Zhu K.; Sun J.; Mu Y.; Li Z.; Guo Y.; miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10. Phytother Res  2023,37(1),295-309","journal-title":"Phytother Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"917329","DOI":"10.3389\/fphar.2022.917329","volume":"13","author":"Li P.","year":"2022","unstructured":"Li P.; Zhang R.; Wang M.; Chen Y.; Chen Z.; Ke X.; Zuo L.; Wang J.; Baicalein prevents fructose-induced hepatic steatosis in rats: In the regulation of fatty acid de novo synthesis, fatty acid elongation and fatty acid oxidation. Front Pharmacol  2022,13,917329","journal-title":"Front Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1158\/0008-5472.CAN-14-1446","volume":"74","author":"Meng X.","year":"2014","unstructured":"Meng X.; Franklin D.A.; Dong J.; Zhang Y.; MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res  2014,74(24),7161-7167","journal-title":"Cancer Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.3390\/ijms241914503","volume":"24","author":"Zhao Z.","year":"2023","unstructured":"Zhao Z.; Li Y.; Guo S.; Chen Y.; Yin H.; Li Y.; Cheng G.; Tian L.; Oryza sativa L. indica seed coat ameliorated concanavalin A-induced acute hepatitis in mice via MDM2\/p53 and PKC\u03b1\/MAPK1 signaling pathways. Int J Mol Sci  2023,24(19),14503","journal-title":"Int J Mol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2200742","DOI":"10.1002\/advs.202200742","volume":"9","author":"Lin H.","year":"2022","unstructured":"Lin H.; Wang L.; Liu Z.; Long K.; Kong M.; Ye D.; Chen X.; Wang K.; Wu K.K.L.; Fan M.; Song E.; Wang C.; Hoo R.L.C.; Hui X.; Hallenborg P.; Piao H.; Xu A.; Cheng K.K.Y.; Hepatic MDM2 causes metabolic associated fatty liver disease by blocking triglyceride-VLDL Secretion via ApoB degradation. Adv Sci (Weinh)  2022,9(20),2200742","journal-title":"Adv Sci (Weinh)"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128328422240820105654","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233912\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128328422240820105654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T14:17:17Z","timestamp":1730470637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233912\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":75,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113816128328422240820105654","relation":{},"ISSN":["1381-6128"],"issn-type":[{"type":"print","value":"1381-6128"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}